{"disease":{"id":"advanced-locally-advanced-and-inoperable-or-metastatic-pd-l1-ic-positive-tnbc","name":"advanced locally advanced and inoperable or metastatic pd l1 ic positive tnbc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03911219","title":"Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"iOMEDICO AG","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}